← Eichor
Study identifier: NCT07534956 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

The Effect of Paedfusor TCI, Eleveld TCI, and Sevoflurane Anesthesia on Postoperative Awakening Agitation in Pediatric Patients

Condition: Emergence Delirium in Pediatric Anesthesia · Pediatric Anesthesia · Postoperative Agitations in Pediatric Patients  ·  Sponsor: Marmara University Pendik Training and Research Hospital

PhaseNA
Planned participants150
Who can joinAll sexes, 3 Years to 10 Years
Healthy volunteersYes

About this study

Emergence delirium is a common complication in pediatric patients undergoing general anesthesia. The aim of this study is to investigate the incidence of postoperative awakening delirium and agitation in pediatric patients aged 3-10 years (ASA I-II) using two different target-controlled infusion (TCI) methods (Paedfusor and Eleveld) for TIVA, compared to inhalation anesthesia. This study will examine the effect of two different TCI models on postoperative awakening agitation/delirium by comparing them with each other and with inhalation anesthesia.

This description comes directly from the study's public registry record.

Talk to the study team

Rukiye Seyma Eslek  ·  +90 539 573 5400  ·  seyma.eslek@gmail.com

Always discuss trial participation with your own doctor first.

Locations (2)

Marmara University Pendik Research and Training HospitalIstanbul, Turkey (Türkiye)Recruiting
Marmara University Pendik Research and Training HospitalIstanbul, Turkey (Türkiye)Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07534956